Synthesis of Biologically Active Bridged Diazabicycloheptanes

G.      Murineddu; B.      Asproni; G.      Pinna; M.M.      Curzu; A.      Dore; A.      Pau; F.      Deligia; G.A.      Pinna

Abstract

The chemistry underlying how diazabicycloheptanes are assembled is described, subdivided according to chemical structure of two types, the 3,6 diazabicyclo[3.1.1]heptane and the 2,5-diazabicyclo[2.2.1]heptane ring system. Detailed information on myriad of activities of compounds derived from the two scaffolds are reported.

Keywords: 3, 6-diazabicyclo[3.1.1]heptanes, 2, 5-diazabicyclo[2.2.1]heptanes, synthesis, antibacterial activity, antitumor activity, antiinflammatory activity, analgesic activity, antipsychotic activity, ischemic injuries, obesity

« Previous Next »

Rights & Permissions Print Cite

Current Medicinal Chemistry

Title:Synthesis of Biologically Active Bridged Diazabicycloheptanes

Volume: 19 Issue: 31

Author(s): G. Murineddu, B. Asproni, G. Pinna, M.M. Curzu, A. Dore, A. Pau, F. Deligia and G.A. Pinna

Affiliation:

Abstract: The chemistry underlying how diazabicycloheptanes are assembled is described, subdivided according to chemical structure of two types, the 3,6 diazabicyclo[3.1.1]heptane and the 2,5-diazabicyclo[2.2.1]heptane ring system. Detailed information on myriad of activities of compounds derived from the two scaffolds are reported.

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Murineddu G., Asproni B., Pinna G., Curzu M.M., Dore A., Pau A., Deligia F. and Pinna G.A., Synthesis of Biologically Active Bridged Diazabicycloheptanes, Current Medicinal Chemistry 2012; 19 (31) . https://dx.doi.org/10.2174/092986712803833317

DOI https://dx.doi.org/10.2174/092986712803833317	Print ISSN 0929-8673
Publisher Name Bentham Science Publisher	Online ISSN 1875-533X

About this journal

Call for Papers in Thematic Issues

Submission closes on : 08 September, 2024

Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.

The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more

Guest Editor(s): Geir Bj?rklund

Submission closes on : 08 July, 2024

Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications

The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more

Guest Editor(s): Igor A. Sobenin

Submission closes on : 14 July, 2024

Chalcogen-modified nucleic acid analogues

Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more

Guest Editor(s): Katarzyna Kulik

Submission closes on : 03 June, 2024

Current advances in inherited cardiomyopathy

Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more

Guest Editor(s): Emmanuel S. Androulakis